By GINA KOLATA
The drug, Keytruda, is the first approved for patients with tumors with a particular genetic signature, wherever they appear in the body.
Published: June 7, 2017 at 08:00PM
from NYT Health http://ift.tt/2sYhsYA
via IFTTT
from WordPress http://ift.tt/2s1kFt2
via IFTTT
No comments:
Post a Comment